106 related articles for article (PubMed ID: 10363970)
1. Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue.
Bièche I; Lidereau R
Cancer Res; 1999 Jun; 59(11):2546-50. PubMed ID: 10363970
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
3. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue.
Dotzlaw H; Leygue E; Watson P; Murphy LC
Clin Cancer Res; 1999 Aug; 5(8):2103-7. PubMed ID: 10473093
[TBL] [Abstract][Full Text] [Related]
4. Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.
Girault I; Andrieu C; Tozlu S; Spyratos F; Bièche I; Lidereau R
Cancer Lett; 2004 Nov; 215(1):101-12. PubMed ID: 15374639
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
Yang T; Zhang JS; Massa SM; Han X; Longo FM
Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues.
Fasco MJ
Anal Biochem; 1997 Feb; 245(2):167-78. PubMed ID: 9056208
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
[TBL] [Abstract][Full Text] [Related]
8. Expression of a novel splicing variant deleting exons 4 and 6 of the progesterone receptor gene is a rare event in breast cancer.
Nagao K; Kohno N; Wakita K; Hikiji K; Yamamoto S; Hirata H; Hisatomi H
Oncol Rep; 2003; 10(2):305-8. PubMed ID: 12579263
[TBL] [Abstract][Full Text] [Related]
9. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.
Jäger D; Stockert E; Scanlan MJ; Güre AO; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 1999 Dec; 59(24):6197-204. PubMed ID: 10626813
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines.
Pfeffer U; Fecarotta E; Castagnetta L; Vidali G
Cancer Res; 1993 Feb; 53(4):741-3. PubMed ID: 7916651
[TBL] [Abstract][Full Text] [Related]
11. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells.
Lu M; Conzen SD; Cole CN; Arrick BA
Cancer Res; 1996 Oct; 56(20):4578-81. PubMed ID: 8840964
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines.
Bernard-Gallon DJ; Vissac-Sabatier C; Antoine-Vincent D; Rio PG; Maurizis JC; Fustier P; Bignon YJ
Br J Nutr; 2002 Apr; 87(4):281-9. PubMed ID: 12064337
[TBL] [Abstract][Full Text] [Related]
13. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
Ghadersohi A; Sood AK
Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
[TBL] [Abstract][Full Text] [Related]
14. Alternatively spliced, truncated human BRCA2 isoforms contain a novel coding exon.
Speevak MD; Young SS; Feilotter H; Ainsworth P
Eur J Hum Genet; 2003 Dec; 11(12):951-4. PubMed ID: 14647209
[TBL] [Abstract][Full Text] [Related]
15. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene.
Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M
J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508
[TBL] [Abstract][Full Text] [Related]
16. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library.
Jäger D; Stockert E; Güre AO; Scanlan MJ; Karbach J; Jäger E; Knuth A; Old LJ; Chen YT
Cancer Res; 2001 Mar; 61(5):2055-61. PubMed ID: 11280766
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of alternatively spliced c-erbB-2 mRNA in primary tumors, lymph node metastases, and bone marrow micrometastases from breast cancer patients.
Gebhardt F; Zänker KS; Brandt B
Biochem Biophys Res Commun; 1998 Jun; 247(2):319-23. PubMed ID: 9642124
[TBL] [Abstract][Full Text] [Related]
18. Structure and expression of variant BRCA2a lacking the transactivation domain.
Zou JP; Hirose Y; Siddique H; Rao VN; Reddy ES
Oncol Rep; 1999; 6(2):437-40. PubMed ID: 10023017
[TBL] [Abstract][Full Text] [Related]
19. Alternately spliced luteinizing hormone/human chorionic gonadotropin receptor mRNA in human breast epithelial cells.
Jiang X; Russo IH; Russo J
Int J Oncol; 2002 Apr; 20(4):735-8. PubMed ID: 11894118
[TBL] [Abstract][Full Text] [Related]
20. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2.
Sorg RV; Enczmann J; Sorg UR; Schneider EM; Wernet P
Exp Hematol; 1993 Apr; 21(4):560-3. PubMed ID: 8462665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
